Breaking News Instant updates and real-time market news.

TXMD

TherapeuticsMD

$6.36

-0.05 (-0.78%)

14:20
10/13/16
10/13
14:20
10/13/16
14:20

Notable call buying in TherapeuticsMD

Notable call buying in TherapeuticsMD. 4300 Dec 7.5 calls bought in a number of sweeps from 65 to 75c this afternoon with shares near $6.36. Volume is 10x the average daily call volume and will create the largest block of open interest in the name. Earnings early Nov.

TXMD TherapeuticsMD
$6.36

-0.05 (-0.78%)

12/08/15
GUGG
12/08/15
NO CHANGE
Target $33
GUGG
Buy
TherapeuticsMD price target raised to $33 from $30 at Guggenheim
Guggenheim analyst William Tanner raised TherapeuticsMD's price target to $33 following the release of top-line data from the REJOICE trial of TX-004 as a treatment for VVA. Tanner said the probability of regulatory approval is high and said rapid treatment effect and low systemic exposure should be important differentiators for this Buy rated stock.
04/04/16
GSCO
04/04/16
INITIATION
Target $10
GSCO
Buy
TherapeuticsMD initiated with a Buy at Goldman
Goldman Sachs analyst Jay Olson started TherapeuticsMD with a Buy rating and $10 price target. With the stock down 40% since the end of December, the analyst believes TherapeuticsMD has been unfairly classified as a biopharma. He views the company's market opportunity as more consumer-like and thinks the stock will return to prior levels.
04/04/16
04/04/16
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Canadian Solar (CSIQ) initiated with an Overweight at Barclays because the company views the company as an "industry-leading" solar module manufacturer with a strong development platform. 2. Marketo (MKTO) initiated with a Buy at Craig-Hallum by analyst Chad Bennett, who said the company is a high growth SaaS company with best in breed marketing automation technology. 3. SolarEdge (SEDG) initiated with an Overweight at Barclays with analyst Jon Windham saying the company's inverter/optimizer solution is positioned for further share gains in the residential/commercial solar segments. 4. TherapeuticsMD (TXMD) initiated with a Buy at Goldman by analyst Jay Olson, who said TherapeuticsMD has been unfairly classified as a biopharma. He views the company's market opportunity as more consumer-like and thinks the stock will return to prior levels. 5. CONSOL (CNX) initiated with a Buy at KLR Group. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
10/10/16
STFL
10/10/16
NO CHANGE
Target $14
STFL
Buy
TherapeuticsMD reiterated as a Best Idea in at Stifel
Stifel analyst Annabel Samimy said TherapeuticsMD remains a Best Idea in Specialty Pharma saying its Yuvverxy is a best in class treatment for VVA in postmenopausal women and E+P for for menopausal symptoms is a large opportunity. The analyst said TherapeuticsMD's products will be mergin just as medical, regulatory, and legislative perceptions are improving. Saminmy rates TherapeuticsMD a Buy with a $14 price target.

TODAY'S FREE FLY STORIES

08:50
09/26/17
09/26
08:50
09/26/17
08:50
General news
Treasury 2-year auction outlook: »

Treasury 2-year auction…

W

Wayfair

$71.23

-3.36 (-4.50%)

08:48
09/26/17
09/26
08:48
09/26/17
08:48
Hot Stocks
Wayfair unveils real-time furniture delivery tracking »

Wayfair announced the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MYSZ

MySize

$0.71

-0.0063 (-0.88%)

08:46
09/26/17
09/26
08:46
09/26/17
08:46
Hot Stocks
MySize awarded first patent »

My Size announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NKE

Nike

$53.23

-0.01 (-0.02%)

, ADDYY

adidas

$113.80

-1.22 (-1.06%)

08:45
09/26/17
09/26
08:45
09/26/17
08:45
Recommendations
Nike, adidas, Under Armour, lululemon analyst commentary  »

Survey respondents more…

NKE

Nike

$53.23

-0.01 (-0.02%)

ADDYY

adidas

$113.80

-1.22 (-1.06%)

UAA

Under Armour

$16.74

0.33 (2.01%)

LULU

lululemon

$57.39

-0.75 (-1.29%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

  • 03

    Oct

  • 04

    Oct

SN

Sanchez Energy

$4.99

0.38 (8.24%)

, SHLD

Sears

$7.14

0.03 (0.42%)

08:45
09/26/17
09/26
08:45
09/26/17
08:45
Options
Largest borrow rate increases among liquid names »

Latest data shows the…

SN

Sanchez Energy

$4.99

0.38 (8.24%)

SHLD

Sears

$7.14

0.03 (0.42%)

USO

United States Oil Fund

$10.55

0.31 (3.03%)

UCO

Universal Compression

$18.28

1.09 (6.34%)

JUNO

Juno Therapeutics

$42.33

-2.81 (-6.23%)

HIMX

Himax

$9.50

-0.66 (-6.50%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

  • 26

    Sep

  • 27

    Sep

  • 08

    Nov

  • 14

    Nov

  • 16

    May

DDAIF

Daimler AG

$78.84

-0.86 (-1.08%)

, TSLA

Tesla

$344.99

-6.1 (-1.74%)

08:44
09/26/17
09/26
08:44
09/26/17
08:44
Periodicals
Daimler responds to Elon Musk tweet on electric vehicles, TechCrunch says »

Daimler (DDAIF) announced…

DDAIF

Daimler AG

$78.84

-0.86 (-1.08%)

TSLA

Tesla

$344.99

-6.1 (-1.74%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Oct

DVCR

Diversicare

$11.10

0.1 (0.91%)

, OHI

Omega Healthcare

$32.45

0.36 (1.12%)

08:43
09/26/17
09/26
08:43
09/26/17
08:43
Hot Stocks
Diversicare, Omega Healthcare agree to terms of new master lease »

Diversicare Healthcare…

DVCR

Diversicare

$11.10

0.1 (0.91%)

OHI

Omega Healthcare

$32.45

0.36 (1.12%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Sep

DRI

Darden

$83.14

0.26 (0.31%)

08:43
09/26/17
09/26
08:43
09/26/17
08:43
Hot Stocks
Darden says expects impact of Hurricane Irma to be double that of Harvey »

Says Irma impact factored…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

AMRS

Amyris

$3.21

-0.29 (-8.29%)

08:42
09/26/17
09/26
08:42
09/26/17
08:42
Hot Stocks
Amyris enters second product development, production agreement with Royal DSM »

Amyris announced that it…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VTR

Ventas

$66.62

0.58 (0.88%)

08:42
09/26/17
09/26
08:42
09/26/17
08:42
Conference/Events
The Executives' Club of Chicago holds a luncheon meeting »

The Executives' Club…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

08:40
09/26/17
09/26
08:40
09/26/17
08:40
General news
U.S. equities are mostly mildly firmer »

U.S. equities are mostly…

08:40
09/26/17
09/26
08:40
09/26/17
08:40
General news
Breaking General news story  »

Week of 9/23 Redbook to…

DRI

Darden

$83.14

0.26 (0.31%)

08:39
09/26/17
09/26
08:39
09/26/17
08:39
Hot Stocks
Breaking Hot Stocks news story on Darden »

Darden says Hurricane…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

NVDA

Nvidia

08:38
09/26/17
09/26
08:38
09/26/17
08:38
Technical Analysis
Technical View: Nvidia bounces back from prior session losses »

The shares were last up…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VCYT

Veracyte

$8.49

0.01 (0.12%)

08:38
09/26/17
09/26
08:38
09/26/17
08:38
Recommendations
Veracyte analyst commentary  »

Veracyte visibility…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

DRI

Darden

$83.14

0.26 (0.31%)

08:36
09/26/17
09/26
08:36
09/26/17
08:36
Hot Stocks
Darden says all businesses 'remain strong' »

Says to-go sales…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

TEUM

Pareteum

$1.06

0.01 (0.95%)

08:35
09/26/17
09/26
08:35
09/26/17
08:35
Hot Stocks
Breaking Hot Stocks news story on Pareteum »

Pareteum Corp trading…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NVEE

NV5 Global

$53.85

2.15 (4.16%)

08:34
09/26/17
09/26
08:34
09/26/17
08:34
Hot Stocks
NV5 Global awarded $14M program management contract by Merced County »

NV5 Global announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Nov

CSBR

Champions Oncology

$3.66

-0.09 (-2.40%)

08:33
09/26/17
09/26
08:33
09/26/17
08:33
Hot Stocks
Champions Oncology awarded $2M from National Cancer Institute »

Champions Oncology…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WIN

Windstream

$1.96

0.03 (1.55%)

, UNIT

Uniti Group

$17.36

0.85 (5.15%)

08:33
09/26/17
09/26
08:33
09/26/17
08:33
Hot Stocks
Windstream says allegations in purported notice of default 'without merit' »

In a regulatory filing…

WIN

Windstream

$1.96

0.03 (1.55%)

UNIT

Uniti Group

$17.36

0.85 (5.15%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Oct

OSIS

OSI Systems

$85.81

-1.08 (-1.24%)

08:32
09/26/17
09/26
08:32
09/26/17
08:32
Hot Stocks
OSI Systems receives $16M in orders for ETD systems »

OSI Systems announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Oct

AXON

Axovant Sciences

$24.25

-0.74 (-2.96%)

08:32
09/26/17
09/26
08:32
09/26/17
08:32
Hot Stocks
Breaking Hot Stocks news story on Axovant Sciences »

Axovant says Mindset…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

GILD

Gilead

$83.61

0.34 (0.41%)

, KITE

Kite Pharma

$179.31

0.01 (0.01%)

08:31
09/26/17
09/26
08:31
09/26/17
08:31
Hot Stocks
Gilead, Kite Pharma announce expiration of HSR waiting period »

Gilead Sciences (GILD)…

GILD

Gilead

$83.61

0.34 (0.41%)

KITE

Kite Pharma

$179.31

0.01 (0.01%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Nov

  • 12

    Feb

08:31
09/26/17
09/26
08:31
09/26/17
08:31
Conference/Events
Federal Reserve Bank of Atlanta President speaks on the economic outlook »

Atlanta Federal Reserve…

CAB

Cabela's

$61.50

0.03 (0.05%)

, SHOR

ShoreTel

08:30
09/26/17
09/26
08:30
09/26/17
08:30
Options
Two option delistings on September 26th »

Option delistings…

CAB

Cabela's

$61.50

0.03 (0.05%)

SHOR

ShoreTel

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.